Clinical Trial Update: Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating secukinumab via AutoiNjector for plaque-type psoriasis; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque-type Psoriasis

Drugs mentioned

• Secukinumab (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Plaque-type Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2018-09-27